Search Results

Printer Friendly
Document Type(s): Bills
Legislative Session(s): 2025-2026
Detailed Category: Health: pharmaceuticals
(5 results found)
Please note: on small devices, or if your browser window is not maximized, you may need to scroll horizontally to see the entire table
Document Type Description
SB 0003 of 2025 Senate Bill Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.
Last Action: referred to Committee on Government Operations
SB 0004 of 2025 Senate Bill Insurance: health insurers; compliance with the prescription drug cost and affordability review act; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406tt. TIE BAR WITH: SB 0003'25
Last Action: referred to Committee on Government Operations
SB 0094 of 2025 Senate Bill Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0095'25
Last Action: referred to Committee on Health Policy
HB 4072 of 2025 House Bill Health: pharmaceuticals; allow patients to take unused portion of eye drops or eye ointments after certain procedures for continued patient care; provide for. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding secs. 17773, 20817 & 21539.
Last Action: referred to second reading
HB 4252 of 2025 House Bill Health: pharmaceuticals; labeling of generic name on pharmaceutical blister packaging; require under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17748g.
Last Action: bill electronically reproduced 03/18/2025